Kina Review
Best for: Women in menopause wanting GLP-1 weight care alongside HRT, from board-certified physicians
Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms. Its GLP-1 program provides compounded semaglutide and tirzepatide from $179/month (plus a $50 physician consult; $0 membership), prescribed and monitored by board-certified physicians at Arora Health & Aesthetics. It carries verifiable LegitScript certification, is FSA/HSA eligible, ships free, and is cancel-anytime. Compounded medications are not FDA-approved; the pharmacy is not named.
What the monthly price covers
Medication
Included
Provider visits
Billed separately
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Kina is a solid telehealth option with balanced features and pricing.
Kina at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $179/mo (GLP-1 program from $179/mo (Kina lists 'GLP-1 Treatment starting at $179/month'); +$50 physician consult, $0 membership; $100 off first month promo. FSA/HSA eligible.)
- What's included
- Medication · Shipping
- FDA status
- No FDA warning letter on record
How we scored Kina
Each dimension is scored algorithmically from Kina’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.8/10At $179/mo, Kina runs about 6% above the $169 median for GLP-1 providers.
Effectiveness25%
9.1/10Kina offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
8.2/10Online intake and platform experience; 8 platform features disclosed.
Trust & Safety15%
8.3/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-28).
Accessibility10%
7.5/10Kina's exact state footprint isn't published — confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
6.9/10Kina provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Kina review
Last checked 2026-06-28- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Kina offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
GLP-1 program from $179/mo (Kina lists 'GLP-1 Treatment starting at $179/month'); +$50 physician consult, $0 membership; $100 off first month promo. FSA/HSA eligible.
$179/mo is the GLP-1 program starting price (compounded tirzepatide also offered); exact tirzepatide pricing confirmed at intake. +$50 consult.
Ready to get started?
Plans and promotions change often — check Kina's current pricing and active discounts before you decide.
What we like
- Menopause-specialized care — GLP-1 weight treatment alongside HRT, peptide, and compounded options for menopause symptoms
- Prescribed and monitored by named board-certified physicians at Arora Health & Aesthetics, with dose adjustments included
- Verifiable LegitScript certification (seal ID 50917967)
- GLP-1 from $179/month with $0 membership fees, FSA/HSA eligibility, free shipping, and cancel-anytime
- Compounded semaglutide and tirzepatide, 100% online with a roughly 2-minute intake
Watch-outs
- Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- Built for women navigating menopause — less tailored if that is not your situation
- A separate $50 physician consultation fee applies on top of the medication price
- The compounding pharmacy partner is not named, and the full list of served states is not published
Is Kina worth it? Our verdict
Kina positions itself around one thing: Women in menopause wanting GLP-1 weight care alongside HRT, from board-certified physicians. It runs $179/month.
How much Kina actually costs
- Compounded semaglutide — $179/month
- Compounded tirzepatide — $179/month
That's roughly in line with the ~$169/month median across the GLP-1 providers we track.
Medications: what Kina prescribes
Kina prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who Kina is best for — and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Kina is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
Ready to start with Kina?
Starting at $179/month. See current pricing and start your free consultation.
Alternatives to Kina
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Kina review:
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Kina?
Starting at $179/month. See current pricing and start your free consultation.